30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Coya Therapeutics Inc (COYA)

Track

Recent insider activity at Coya Therapeutics Inc. shows multiple 'BUY' transactions by executives, including the Chief Financial Officer, Chief Executive Officer, and Chief Medical Officer, occurring in November 2024. The most recent trading activity was on November 14, 2024. Prior to this, significant buying activity was noted in August 2023 and January 2023.
Stock chart
Ticker: COYA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
SNYDER DAVID S
Chief Financial Officer
1 purchase — total 12,934 USD
Buy 14 Nov 2024
Value US$4,028,930.88 | Price 422.54 | Shares 21,850
Buy 13 Nov 2024
Value US$388,878.28 | Price 177.98 | Shares 53,382
Buy 11 Nov 2024
Value US$36,689.00 | Price 7.34 | Shares 5,000
Buy 11 Nov 2024
Value US$19,972.70 | Price 7.37 | Shares 2,710
Buy 22 Aug 2023
Value US$3,620.00 | Price 3.62 | Shares 1,000
Buy 3 Jan 2023
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 3 Jan 2023
Value US$0.00 | Price 0.00 | Shares 7,000
Buy 3 Jan 2023
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 3 Jan 2023
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 3 Jan 2023
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 3 Jan 2023
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 3 Jan 2023
Value US$0.00 | Price 0.00 | Shares 2,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-14 2024-11-14 B Purchase
3.4
SNYDER DAVID S

Chief Financial Officer

Officer
21,850 -18.8%
422.54
US$4,028,931 		21,850 -18.8% 422.54 US$4,028,931
2024-11-13 2024-11-13 B Purchase
1.1
Swaminathan Arun

Chief Executive Officer

Executive Director
53,382 -20.6%
177.98
US$388,878 		53,382 -20.6% 177.98 US$388,878
2024-11-12 2024-11-11 B Purchase
1.1
Swaminathan Arun

Chief Executive Officer

Executive Director
49,012 +30.1%
363.57
US$79,163 		49,012 +30.1% 363.57 US$79,163
2024-11-12 2024-11-11 B Purchase
0.8
Grossman Fred

Chief Medical Officer

Officer
2,710 +inf%
7.37
US$19,973 		2,710 +inf% 7.37 US$19,973
2024-03-05 2023-08-22 B Purchase
3.3
Lee Ann
Non-Executive Director
1,000 +6.1%
3.62
US$3,620 		1,000 +6.1% 3.62 US$3,620
2023-01-04 2023-01-03 B Purchase
Berman Howard

Chief Executive Officer

Executive Director Large shareholder
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
3.4
SNYDER DAVID S

Chief Financial Officer

Officer
7,000
0.00
US$0 		7,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
Hepner Adrian

Chief Medical Officer

Officer
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
0.6
GOLDSTEIN DOV A MD
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
Villalobos Anabella
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
3.3
Lee Ann
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
Garren Hideki
Non-Executive Director
2,000
0.00
US$0 		2,000 0.00 US$0
Explore more

More insider trading research around Coya Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America